Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell Transplantation

Clinical trial NCT05005299 · UNKNOWN

Trial details

NCT number: NCT05005299
Sponsor: Melbourne Health
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Leukemia, Myeloid, Acute Leukemia, Lymphoblastic, Acute, L1 Leukemia, Lymphoblastic, Acute, L2 Myelodysplastic Syndromes Non-hodgkin Lymphoma Plasma Cell Myeloma

Start date: 2022-06-08
Primary completion: 2026-03-31
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.